|
DEPDC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.040400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.517400E-01 |
| Normal-vs-Stage2 |
9.917000E-01 |
| Normal-vs-Stage3 |
4.972200E-02 |
| Normal-vs-Stage4 |
4.252600E-01 |
| Stage1-vs-Stage2 |
9.282400E-01 |
| Stage1-vs-Stage3 |
3.280000E-02 |
| Stage1-vs-Stage4 |
5.661000E-01 |
| Stage2-vs-Stage3 |
1.827580E-01 |
| Stage2-vs-Stage4 |
6.334200E-01 |
| Stage3-vs-Stage4 |
5.017600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.900000E-01 |
| Normal-vs-AfricanAmerican |
6.545600E-01 |
| Normal-vs-Asian |
3.923800E-01 |
| Caucasian-vs-AfricanAmerican |
6.551600E-01 |
| Caucasian-vs-Asian |
6.313800E-01 |
| AfricanAmerican-vs-Asian |
4.679000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.532400E-01 |
| Normal-vs-Female |
8.233400E-01 |
| Male-vs-Female |
8.469600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.166410E-01 |
| Normal-vs-Extreme_Weight |
4.048200E-01 |
| Normal-vs-Obese |
5.206400E-01 |
| Normal-vs-Extreme_Obese |
9.099800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.295000E-01 |
| Normal_Weight-vs-Obese |
3.856200E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.920400E-01 |
| Extreme_Weight-vs-Obese |
1.822980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.296000E-01 |
| Obese-vs-Extreme_Obese |
8.404000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.706000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.093000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.732400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.703000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.221200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.278000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.488000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.568200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.679400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.293800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.676200E-01 |
| Normal-VS-Type2 PRCC |
3.510800E-01 |
| Normal-VS-KIRP CIMP |
1.905830E-01 |
| Normal-VS-Unclassified PRCC |
7.146200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.125800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.898190E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.430200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.266200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.967400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.236200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.840000E-01 |
| Normal-vs-N1 |
9.727800E-01 |
| Normal-vs-N2 |
9.853200E-01 |
| N0-vs-N1 |
5.807000E-01 |
| N0-vs-N2 |
7.956800E-01 |
| N1-vs-N2 |
9.928400E-01 |
|
|
